Climb Bio (CLYM) Change in Accured Expenses (2020 - 2026)
Climb Bio (CLYM) posted Change in Accured Expenses of -$1.5 million for Q1 2026, down 796.36% on a QoQ basis from $220000.0 in Q4 2025, and down 175.28% year-over-year from $2.0 million in Q1 2025.
Climb Bio (CLYM) Change in Accured Expenses (2020 - 2026) Analysis & Trends
Climb Bio's Change in Accured Expenses history runs 7 years deep, the most recent figure standing at -$1.5 million for Q1 2026.
- Quarterly Change in Accured Expenses fell 175.28% year-over-year to -$1.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$3.2 million (down 175.62% YoY) and the FY2025 annual result came in at $372000.0, down 74.26% from the prior year.
- Change in Accured Expenses was -$1.5 million for Q1 2026 at Climb Bio, down from $220000.0 in the prior quarter.
- Across five years, Change in Accured Expenses topped out at $2.0 million in Q1 2025 and bottomed at -$1.7 million in Q3 2022.
- A 5-year average of -$111941.2 and a median of $95000.0 in 2024 frame the typical range for Change in Accured Expenses.
- Peak annual rise in Change in Accured Expenses reached 373.15% in 2025, while the deepest fall reached 933.68% in 2025.
- Climb Bio's Change in Accured Expenses stood at $613000.0 in 2022, then rose by 9.3% to $670000.0 in 2023, then surged by 52.84% to $1.0 million in 2024, then plunged by 78.52% to $220000.0 in 2025, then plunged by 796.36% to -$1.5 million in 2026.
- Business Quant data shows CLYM's Change in Accured Expenses at -$1.5 million in Q1 2026, $220000.0 in Q4 2025, and -$792000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 1.13 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | -16.82 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 23.10 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 107.70 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -16.74 Mn |
| 10 | Climb Bio | 870.33 Mn | 870.33 Mn | - | -1.53 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.53 Mn |
| Mar 31, 2026 | -1.53 Mn |
| Dec 31, 2025 | 220,000.00 |
| Dec 31, 2025 | 220,000.00 |
| Sep 30, 2025 | -792,000.00 |
| Sep 30, 2025 | -792,000.00 |
| Jun 30, 2025 | -1.09 Mn |
| Jun 30, 2025 | -1.09 Mn |
| Mar 31, 2025 | 2.04 Mn |
| Mar 31, 2025 | 2.04 Mn |
| Dec 31, 2024 | 1.02 Mn |
| Dec 31, 2024 | 1.02 Mn |
| Sep 30, 2024 | 95,000.00 |
| Sep 30, 2024 | 95,000.00 |
| Jun 30, 2024 | 1.07 Mn |
| Jun 30, 2024 | 1.07 Mn |
| Mar 31, 2024 | -745,000.00 |
| Mar 31, 2024 | -745,000.00 |
| Dec 31, 2023 | 670,000.00 |
| Dec 31, 2023 | 670,000.00 |